Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

NCT02293863 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT02293863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 14, 2015
Completion date
May 23, 2017
Enrollment
168 (actual)
Sites
171

Conditions

As the registry lists them; a condition with its own page is linked.

influenza